Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity

Hepatology

Volumn 57, Issue 1, 2013, Pages 140-151

  Guo, Yuanyuan ^a,b   Wang, Wendie ^a,b   Wang, Jing ^a   Feng, Jiannan ^a   Wang, Qingyang ^a   Jin, Jianfeng ^a   Lv, Ming ^a   Li, Xinying ^a   Li, Yan ^a   Ma, Yuanfang ^a,b   Shen, Beifen ^a   Zhang, Jiyan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b HENAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; RECEPTOR FOR ACTIVATED C KINASE 1; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CANCER TISSUE; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GAIN OF FUNCTION MUTATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LOSS OF FUNCTION MUTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN PROTEIN INTERACTION; TISSUE LEVEL; TUMOR PROMOTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; FEMALE; GTP-BINDING PROTEINS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; LIVER NEOPLASMS; MALE; MAP KINASE KINASE 7; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; MIDDLE AGED; NEOPLASM PROTEINS; RECEPTORS, CELL SURFACE; YOUNG ADULT;

EID: 84872127055     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25978     Document Type: Article

References (25)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917.
2. Takekawa M, Tatebayashi K, Saito H. Conserved docking site is essential for activation of mammalian MAP kinase kinase by specific MAP kinase kinase kinase. Mol Cell 2005; 18: 295-306.
3. Lin A. Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays 2003; 25: 17-24.
4. Yu C, Minemoto Y, Zhang J, Liu J, Tang F, Bui TN, et al. JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol Cell 2004; 13: 329-340.
5. Lu X, Nemoto S, Lin A. Identification of c-Jun NH2-terminal protein kinase (JNK)-activating kinase 2 as an activator of JNK but not p38. J Biol Chem 1997; 272: 24751-24754.
6. Hui L, Zatloukal K, Scheuch H, Stepniak E, Wagner EF. Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J Clin Invest 2008; 118: 3943-3953.
7. Chang Q, Chen J, Beezhold KJ, Castranova V, Shi, X, Chen F. JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma. Mol Cancer 2009; 8: 64.
8. Chang Q, Zhang Y, Beezhold KJ, Bhatia D, Zhao H, Chen J, et al. Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer. J Hepatol 2009; 50: 323-333.
9. Nagata H, Hatamo E, Tada M, Murata M, Kitamura K, Asechi H, et al. Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor-suppression in rat hepatocellular carcinoma. HEPATOLOGY 2009; 49: 1944-1953.
10. Hui L, Bakiri L, Mairhorfer A, Schweifer N, Haslinger C, Kenner L, et al. p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat Genet 2007; 39: 741-749.
11. Sakurai T, Maeda S, Chang L, Karin M. Loss of hepatic NF-kappaB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc Natl Acad Sci U S A 2006; 103: 10544-10551.
12. Mucha SR, Rizzani A, Gerbes AL, Camaj P, Thasler WE, Bruns CJ, et al. JNK inhibition sensitizes hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand. Gut 2009; 58: 688-698.
13. Kuntzen C, Sonuc N, De Toni EN, Opelz C, Mucha SR, Gerbes AL, Eichhorst ST. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest. Cancer Res 2005; 65: 6780-6788.
14. Lopez-Bergami P, Habelhah H, Bhoumik A, Zhang W, Wang LH, Ronia Z. RACK1 mediates activation of JNK by protein kinase C. Mol Cell 2005; 19: 309-320.
15. Arimoto K, Fukuda H, Imajoh-Ohmi S, Saito H, Takekawa M. Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nat Cell Biol 2008; 10: 1324-1332.
16. Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M, et al. Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 2007; 11: 447-460.
17. Yoon SY, Kim JM, Oh JH, Jeon YJ, Lee DS, Kim JH, et al. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags. Int J Oncol 2006; 29: 315-327.
18. Bourd-Boittin K, Le Pabic H, Bonnier D, L'Helgoualc'h A, Théret N. RACK1, a new ADAM12 interacting protein: contribution to liver fibrogenesis. J Biol Chem 2008; 283: 2600-2609.
19. Westwick JK, Weitzel C, Leffert HL, Brenner DA. Activation of Jun kinase is an early event in hepatic regeneration. J Clin Invest 1995; 95: 803-810.
20. Wang J, Tang R, Lv M, Wang Q, Zhang X, Guo Y, et al. Defective anchoring of JNK1 in the cytoplasm by MKK7 in Jurkat cells is associated with resistance to Fas-mediated apoptosis. Mol Biol Cell 2011; 22: 117-127.
21. Adams DR, Ron D, Kiely PA. RACK1, a multifaceted scaffolding protein: structure and function. Cell Commun Signal 2011; 9: 22.
22. Li H, Ren Z, Kang X, Zhang L, Li X, Wang Y, et al. Identification of tyrosine-phosphoeylated proteins associated with metastasis and functional analysis of FER in human hepatocellular carcinoma cells. BMC Cancer 2009; 9: 366.
23. Wada T, Joza N, Cheng HM, Sasaki T, Kozieradzki I, Bachmaier K, et al. MKK7 couples tress signaling to G2/M cell-cycle progression and cellular senescence. Nat Cell Biol 2004; 6: 215-226.
24. Marasa BS, Srikantan S, Masuda K, Abdelmohsen K, Kuwano Y, Yang X, et al. Increased MKK4 abundance with replicative senescence is linked to the joint reduction of multiple microRNAs. Sci Signal 2009; 2: ra69.
25. Ahn YH, Yang Y, Gibbons DL, Creighton CJ, Yang F, Wistuba II, et al. Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor γ2 expression. Mol Cell Biol 2011; 31: 4270-4285.